117 related articles for article (PubMed ID: 32642853)
41. Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics.
Peris P; Parés A; Guañabens N; Pons F; Martínez de Osaba MJ; Caballería J; Rodés J; Muñoz-Gómez J
Alcohol Alcohol; 1992 Nov; 27(6):619-25. PubMed ID: 1292434
[TBL] [Abstract][Full Text] [Related]
42. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
[TBL] [Abstract][Full Text] [Related]
43. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
45. Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis.
Wildberger L; Boyadzhieva V; Hans D; Stoilov N; Rashkov R; Aubry-Rozier B
Joint Bone Spine; 2017 Jul; 84(4):463-466. PubMed ID: 27450198
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
Strandberg S; Nordström P; Lorentzon R; Lorentzon M
J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
[TBL] [Abstract][Full Text] [Related]
47. Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
Choi HS; Park JH; Kim SH; Shin S; Park MJ
Osteoporos Int; 2017 Mar; 28(3):955-964. PubMed ID: 27747365
[TBL] [Abstract][Full Text] [Related]
48. Osteoporosis and determinants of bone density in patients with Crohn's disease.
Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF
Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142
[TBL] [Abstract][Full Text] [Related]
49. Bone demineralisation in a large cohort of Wilson disease patients.
Weiss KH; Van de Moortele M; Gotthardt DN; Pfeiffenberger J; Seessle J; Ullrich E; Gielen E; Borghs H; Adriaens E; Stremmel W; Meersseman W; Boonen S; Cassiman D
J Inherit Metab Dis; 2015 Sep; 38(5):949-56. PubMed ID: 25663473
[TBL] [Abstract][Full Text] [Related]
50. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
[TBL] [Abstract][Full Text] [Related]
52. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).
Tenenhouse A; Joseph L; Kreiger N; Poliquin S; Murray TM; Blondeau L; Berger C; Hanley DA; Prior JC;
Osteoporos Int; 2000; 11(10):897-904. PubMed ID: 11199195
[TBL] [Abstract][Full Text] [Related]
53. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
[TBL] [Abstract][Full Text] [Related]
54. Increased Bone Mineral Density in Cervical or Thoracic Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Case-Control Study.
Sohn S; Chung CK; Han I; Park SB; Kim H
J Clin Densitom; 2018; 21(1):68-74. PubMed ID: 27712986
[TBL] [Abstract][Full Text] [Related]
55. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
[TBL] [Abstract][Full Text] [Related]
57. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
58. Predictors of bone mass in healthy older men in the community.
Smerdely P; Seller M; Smith A; Day P; Diamond T
Med J Aust; 2000 Aug; 173(4):183-6. PubMed ID: 11008590
[TBL] [Abstract][Full Text] [Related]
59. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
60. Impact of degenerative spinal diseases on bone mineral density of the lumbar spine in elderly women.
Muraki S; Yamamoto S; Ishibashi H; Horiuchi T; Hosoi T; Orimo H; Nakamura K
Osteoporos Int; 2004 Sep; 15(9):724-8. PubMed ID: 14997287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
